Elevation Spine lands FDA clearance for expandable interbody fusion system

Elevation Spine has obtained US Food and Drug Administration (FDA) clearance for Saber-XA, an anterior lumbar interbody fusion (ALIF) system with an expandable cage for degenerative disc disease treatment and spinal column stabilization.

Elevation highlighted that due to Saber-XA’s form factor, surgeons can independently adjust the implant’s height angle based on individual patient anatomy.

FDA clearance for Saber-XA comes weeks after the California-based company secured FDA clearance for Saber-C AVIA, a cervical fixation device to treat spinal pathologies including nerve compression by stabilizing the vertebrae, damaged disc replacements, and to promote bone fusion.

Elevation’s CEO, Charlie Gilbride, commented: “This clearance represents exactly what we set out to achieve with Saber-XA: true intra-operative customisation of height and lordosis, something no competing ALIF system offers in combination with both spike and screw fixation along with an anterior lumbar plate.”

Read more about the new product launch here